- Home
- SONN vs AVGR Comparison
SONN vs AVGR Comparison
Compare SONN & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- AVGR
- Stock Information
- Founded
- SONN N/A
- AVGR 2007
- Country
- SONN United States
- AVGR United States
- Employees
- SONN N/A
- AVGR N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- AVGR Medical/Dental Instruments
- Sector
- SONN Health Care
- AVGR Health Care
- Exchange
- SONN Nasdaq
- AVGR Nasdaq
- Market Cap
- SONN 2.5M
- AVGR 2.0M
- IPO Year
- SONN N/A
- AVGR 2015
- Fundamental
- Price
- SONN $1.51
- AVGR $1.05
- Analyst Decision
- SONN Strong Buy
- AVGR Strong Buy
- Analyst Count
- SONN 2
- AVGR 1
- Target Price
- SONN $38.00
- AVGR $5.00
- AVG Volume (30 Days)
- SONN 2.8M
- AVGR 6.1M
- Earning Date
- SONN 12-17-2024
- AVGR 11-07-2024
- Dividend Yield
- SONN N/A
- AVGR N/A
- EPS Growth
- SONN N/A
- AVGR N/A
- EPS
- SONN N/A
- AVGR N/A
- Revenue
- SONN $18,626.00
- AVGR $7,262,000.00
- Revenue This Year
- SONN N/A
- AVGR N/A
- Revenue Next Year
- SONN N/A
- AVGR $93.49
- P/E Ratio
- SONN N/A
- AVGR N/A
- Revenue Growth
- SONN N/A
- AVGR N/A
- 52 Week Low
- SONN $1.41
- AVGR $0.39
- 52 Week High
- SONN $18.72
- AVGR $5.45
- Technical
- Relative Strength Index (RSI)
- SONN 26.27
- AVGR 60.90
- Support Level
- SONN $1.41
- AVGR $0.45
- Resistance Level
- SONN $1.94
- AVGR $1.93
- Average True Range (ATR)
- SONN 0.37
- AVGR 0.22
- MACD
- SONN 0.05
- AVGR 0.07
- Stochastic Oscillator
- SONN 2.91
- AVGR 51.31
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.